CHRISTINE FIORENTINO: Open Payments
NPI 1033531892 · SPOKANE VALLEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,368 in 102 payments from 35 companies in 2025. Trend: 2023 $588 · 2024 $1,004 · 2025 $2,368
Food & beverage: $2,368
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $306 |
| Novartis Pharmaceuticals Corporation | 21 | $281 |
| REVANCE THERAPEUTICS, INC. | 3 | $185 |
| PFIZER INC. | 11 | $173 |
| GENZYME CORPORATION | 1 | $150 |
| GlaxoSmithKline, LLC. | 5 | $96 |
| Merck Sharp & Dohme LLC | 4 | $91 |
| Incyte Corporation | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Janssen Biotech, Inc. | 4 | $77 |
Products named: DAXXIFY, IMFINZI, SARCLISA, Enhertu, KEYTRUDA, Fabhalta, SCEMBLIX, OJJAARA.
Industry payments across WA — which companies pay providers there.
